News - Boehringer Ingelheim
2012-05-31 02:26:56
RIDGEFIELD, Conn. and NEW YORK, May 31, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
2012-05-25 23:02:37
The Pradaxa Resource Center is the Web’s largest source for information on Pradaxa research, side effects and legal news.
2012-05-24 02:28:31
RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
2012-05-22 06:25:33
SAN FRANCISCO, May 22, 2012 /PRNewswire/ -- Boehringer Ingelheim announced today results from a Phase II study evaluating the investigational compound tiotropium delivered once-daily via the
2012-05-21 10:23:18
SAN FRANCISCO, May 21, 2012 /PRNewswire/ -- Data from a Phase II trial of olodaterol presented today at the 2012 Annual International Conference of the American Thoracic Society (ATS 2012)